跳到正文
原文
Moderna· @moderna_tx · X·· 6 天前AI 评分42
AI 导读

今日我们宣布,@JAMANetworkOpen 发表了一项大型真实世界研究结果,该研究评估了 mNEXSPIKE®(COVID-19 疫苗,mRNA)与 Comirnaty®(COVID-19 疫苗,mRNA)在 2025-2026 呼吸道病毒流行季期间、65 岁及以上美国退伍军人中的比较有效性。 阅读更多:https://lnkd.in/eVS6kvA4

正文

Today we announced a publication in @JAMANetworkOpen of results from a large real-world study evaluating the comparative effectiveness of mNEXSPIKE® (COVID-19 Vaccine, mRNA) and Comirnaty® (COVID-19 Vaccine, mRNA) among U.S. Veterans aged 65 years and older during the 2025-2026 respiratory virus season.

Read more: https://lnkd.in/eVS6kvA4

来源:Moderna · x.com